The effect of cyclosporine A on infection of susceptible cells by human immunodeficiency virus type 1 - PubMed (original) (raw)
Comparative Study
. 1988 Dec;72(6):1904-10.
Affiliations
- PMID: 2904290
Free article
Comparative Study
The effect of cyclosporine A on infection of susceptible cells by human immunodeficiency virus type 1
M A Wainberg et al. Blood. 1988 Dec.
Free article
Abstract
The effect of cyclosporine A (CyA) on the ability of the human immunodeficiency virus type 1 (HIV-1) to infect the H-9 T-cell leukemic line, as well as interleukin-2 (IL-2)-grown human peripheral blood-derived lymphocytes, has been studied. Pretreatment of H-9 cells and human lymphocytes with CyA over 24 hours completely prevented viral infection over a 21-day period, whereas the addition of drug at two hours postinfection with HIV-1 had a significant inhibitory effect on viral replication and expression of the virus-specific antigens p17 and p24. However, if CyA was added at later times to these lymphocytic cells, this inhibitory effect was lost. Indeed, the removal of CyA from cultures that had been treated from two hours after infection led to the rapid production of progeny virus. HIV-1 was able to infect peripheral blood lymphocytes obtained from each of four kidney allograft recipients on long-term CyA antirejection therapy, as long as drug was not included in the culture medium. In addition, we asked what effect pretreatment with CyA of cells of the U-937 monocytic line and primary cultures of human monocytes/macrophages might have on infection by HIV-1. CyA had no demonstrable effect on the ability of HIV-1 to infect cells of either type.
Similar articles
- Tumor necrosis factor alpha inhibits entry of human immunodeficiency virus type 1 into primary human macrophages: a selective role for the 75-kilodalton receptor.
Herbein G, Montaner LJ, Gordon S. Herbein G, et al. J Virol. 1996 Nov;70(11):7388-97. doi: 10.1128/JVI.70.11.7388-7397.1996. J Virol. 1996. PMID: 8892857 Free PMC article. - Inhibition of human immunodeficiency virus replication in differentiating monocytes by interleukin 10 occurs in parallel with inhibition of cellular RNA expression.
Naif HM, Chang J, Ho-Shon M, Li S, Cunningham AL. Naif HM, et al. AIDS Res Hum Retroviruses. 1996 Sep 1;12(13):1237-45. doi: 10.1089/aid.1996.12.1237. AIDS Res Hum Retroviruses. 1996. PMID: 8870845 - Interference of interleukin-10 with human immunodeficiency virus type 1 replication in primary monocyte-derived macrophages.
Kootstra NA, van 't Wout A, Huisman HG, Miedema F, Schuitemaker H. Kootstra NA, et al. J Virol. 1994 Nov;68(11):6967-75. doi: 10.1128/JVI.68.11.6967-6975.1994. J Virol. 1994. PMID: 7933078 Free PMC article. - Interleukin-10 suppresses human immunodeficiency virus-1 replication in vitro in cells of the monocyte/macrophage lineage.
Saville MW, Taga K, Foli A, Broder S, Tosato G, Yarchoan R. Saville MW, et al. Blood. 1994 Jun 15;83(12):3591-9. Blood. 1994. PMID: 7911340
Cited by
- Cyclophilin inhibition as a strategy for the treatment of human disease.
Stauffer WT, Goodman AZ, Gallay PA. Stauffer WT, et al. Front Pharmacol. 2024 Jul 8;15:1417945. doi: 10.3389/fphar.2024.1417945. eCollection 2024. Front Pharmacol. 2024. PMID: 39045055 Free PMC article. Review. - Gene expression analysis of a panel of cell lines that differentially restrict HIV-1 CA mutants infection in a cyclophilin a-dependent manner.
Shah VB, Aiken C. Shah VB, et al. PLoS One. 2014 Mar 24;9(3):e92724. doi: 10.1371/journal.pone.0092724. eCollection 2014. PLoS One. 2014. PMID: 24663101 Free PMC article. - Target cell type-dependent modulation of human immunodeficiency virus type 1 capsid disassembly by cyclophilin A.
Li Y, Kar AK, Sodroski J. Li Y, et al. J Virol. 2009 Nov;83(21):10951-62. doi: 10.1128/JVI.00682-09. Epub 2009 Aug 5. J Virol. 2009. PMID: 19656870 Free PMC article. - Inhibition of human immunodeficiency virus replication by nonimmunosuppressive analogs of cyclosporin A.
Bartz SR, Hohenwalter E, Hu MK, Rich DH, Malkovsky M. Bartz SR, et al. Proc Natl Acad Sci U S A. 1995 Jun 6;92(12):5381-5. doi: 10.1073/pnas.92.12.5381. Proc Natl Acad Sci U S A. 1995. PMID: 7777516 Free PMC article. - The use of cyclosporine for recurrent hepatitis C after liver transplant: a randomized pilot study.
Firpi RJ, Soldevila-Pico C, Morelli GG, Cabrera R, Levy C, Clark VC, Suman A, Michaels A, Chen C, Nelson DR. Firpi RJ, et al. Dig Dis Sci. 2010 Jan;55(1):196-203. doi: 10.1007/s10620-009-0981-3. Dig Dis Sci. 2010. PMID: 19798576 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources